Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-06-08 Purchase |
2023-06-08 8:54 pm |
Erasca Inc. | ERAS | Lim Jonathan E Chairman & CEO 10% Owner |
100,000 | $2.75 | $275,000 | 30,295,576 (Indirect) |
View |
| 2023-04-10 Purchase |
2023-04-11 08:23 am |
Erasca Inc. | ERAS | Casdin Alexander W. Director |
20,000 | $2.7615 | $55,230 | 557,724 (Indirect Direct) |
View |
| 2023-03-28 Purchase |
2023-03-28 9:24 pm |
Erasca Inc. | ERAS | Lim Jonathan E Chairman & CEO 10% Owner |
100,000 | $2.84 | $284,000 | 30,195,576 (Indirect) |
View |
| 2023-01-10 Purchase |
2023-01-10 4:46 pm |
Erasca Inc. | ERAS | Lim Jonathan E Chairman & CEO 10% Owner |
60,000 | $3.857 | $231,420 | 32,155,582 (Indirect) |
View |
| 2022-12-21 Purchase |
2022-12-22 9:28 pm |
Erasca Inc. | ERAS | Start Valerie Denise Harding Director |
10,000 | $4.64 | $46,400 | 12,000 (Indirect Direct) |
View |
| 2022-12-21 Purchase |
2022-12-22 9:26 pm |
Erasca Inc. | ERAS | Bristol James Arthur Director |
20,000 | $4.14 | $82,800 | 207,500 (Indirect Direct) |
View |
| 2022-12-13 Purchase(A) |
2022-12-21 4:33 pm |
Erasca Inc. | ERAS | Chen Bihua Cormorant Asset Management LP Cormorant Global Healthcare Master Fund LP Cormorant Private Healthcare Fund II LP Director |
307,692 | $6.5 | $1,999,998 | 11,019,912 (Indirect Direct) |
View |
| 2022-12-13 Purchase |
2022-12-20 5:42 pm |
Erasca Inc. | ERAS | Chen Bihua Cormorant Asset Management LP Cormorant Global Healthcare Master Fund LP Cormorant Private Healthcare Fund II LP Director |
307,692 | $6.5 | $1,999,998 | 11,019,912 (Indirect Direct) |
View |
| 2022-12-15 Purchase |
2022-12-15 4:47 pm |
Erasca Inc. | ERAS | Casdin Alexander W. Director |
20,000 | $4.8745 | $97,490 | 537,724 (Indirect Direct) |
View |
| 2022-12-14 Purchase |
2022-12-15 11:53 am |
Erasca Inc. | ERAS | Lim Jonathan E Chairman & CEO 10% Owner |
40,000 | $4.99 | $199,600 | 32,095,582 (Indirect) |
View |
| 2021-08-10 Purchase |
2021-08-10 4:02 pm |
Erasca Inc. | ERAS | Chen Bihua Director |
200,000 | $22.1 | $4,420,000 | 10,672,219 (Indirect Direct) |
View |
| 2021-07-26 Sale |
2021-08-10 4:02 pm |
Erasca Inc. | ERAS | Chen Bihua Director |
200,000 | $18.77 | $3,753,000 | 10,672,219 (Indirect Direct) |
View |
| 2021-07-20 Purchase |
2021-07-22 4:10 pm |
Erasca Inc. | ERAS | Chen Bihua Cormorant Global Healthcare Master Fund LP Cormorant Asset Management LP Cormorant Private Healthcare Fund II LP Director |
950,000 | $16 | $15,200,000 | 10,672,219 (Indirect Direct) |
View |
| 2021-07-20 Purchase |
2021-07-20 8:57 pm |
Erasca Inc. | ERAS | Garner Ebun General Counsel |
900 | $16 | $14,400 | 900 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-06-22 Option Award |
2023-06-26 09:11 am |
2024-06-22 2033-06-21 |
Erasca Inc. | ERAS | Start Valerie Denise Harding Director |
60,000 | $0 | 60,000 (Direct) |
View |
| 2023-06-22 Option Award |
2023-06-26 09:10 am |
2024-06-22 2033-06-21 |
Erasca Inc. | ERAS | Hambleton Julie Director |
60,000 | $0 | 60,000 (Direct) |
View |
| 2023-06-22 Option Award |
2023-06-26 09:09 am |
2024-06-22 2033-06-21 |
Erasca Inc. | ERAS | Casdin Alexander W. Director |
60,000 | $0 | 60,000 (Direct) |
View |
| 2023-06-22 Option Award |
2023-06-26 09:09 am |
2024-06-22 2033-06-21 |
Erasca Inc. | ERAS | Bristol James Arthur Director |
60,000 | $0 | 60,000 (Direct) |
View |
| 2023-04-10 Option Award |
2023-04-13 8:26 pm |
N/A 2033-04-09 |
Erasca Inc. | ERAS | Morris Shannon Chief Medical Officer |
375,000 | $0 | 375,000 (Direct) |
View |
Ownership |
2023-04-13 8:21 pm |
N/A 2032-05-01 |
Erasca Inc. | ERAS | Morris Shannon Chief Medical Officer |
0 | $0 | 460,800 (Direct) |
View |
Ownership |
2023-02-15 8:55 pm |
N/A N/A |
Erasca Inc. | ERAS | Lim Jonathan E Chairman and CEO 10% Owner |
0 | $0 | 30,095,576 (Indirect) |
View |
| 2022-11-30 Ownership |
2023-02-15 8:55 pm |
N/A N/A |
Erasca Inc. | ERAS | Lim Jonathan E Chairman and CEO 10% Owner |
2,000,006 | $0 | 30,095,576 (Indirect) |
View |
| 2023-02-01 Option Award |
2023-02-03 08:55 am |
N/A 2033-01-31 |
Erasca Inc. | ERAS | Lim Jonathan E Chairman & CEO 10% Owner |
1,500,000 | $0 | 1,500,000 (Direct) |
View |
| 2023-02-01 Other |
2023-02-03 08:54 am |
N/A N/A |
Erasca Inc. | ERAS | Chacko David M. Chief Financial Officer |
1,748 | $4.097 | 840,998 (Direct) |
View |
| 2023-02-01 Option Award |
2023-02-03 08:54 am |
N/A 2033-01-31 |
Erasca Inc. | ERAS | Chacko David M. Chief Financial Officer |
600,000 | $0 | 840,998 (Direct) |
View |
| 2023-02-01 Other |
2023-02-03 08:54 am |
N/A N/A |
Erasca Inc. | ERAS | Chacko David M. Chief Financial Officer |
2 | $3.893 | 840,998 (Direct) |
View |
| 2023-02-01 Other |
2023-02-03 08:53 am |
N/A N/A |
Erasca Inc. | ERAS | Wei Lin Chief Medical Officer |
1,748 | $4.097 | 877,562 (Direct) |
View |
| 2023-02-01 Option Award |
2023-02-03 08:53 am |
N/A 2033-01-31 |
Erasca Inc. | ERAS | Wei Lin Chief Medical Officer |
560,000 | $0 | 877,562 (Direct) |
View |
| 2023-02-01 Other |
2023-02-03 08:53 am |
N/A N/A |
Erasca Inc. | ERAS | Wei Lin Chief Medical Officer |
2 | $3.893 | 877,562 (Direct) |
View |
| 2023-02-01 Other |
2023-02-03 08:53 am |
N/A N/A |
Erasca Inc. | ERAS | Garner Ebun General Counsel & Corp. Sec. |
2,388 | $4.097 | 486,670 (Direct) |
View |
| 2023-02-01 Option Award |
2023-02-03 08:53 am |
N/A 2033-01-31 |
Erasca Inc. | ERAS | Garner Ebun General Counsel & Corp. Sec. |
480,000 | $0 | 486,670 (Direct) |
View |
| 2023-02-01 Other |
2023-02-03 08:53 am |
N/A N/A |
Erasca Inc. | ERAS | Garner Ebun General Counsel & Corp. Sec. |
2 | $3.893 | 486,670 (Direct) |
View |
| 2022-07-01 Other |
2022-07-06 7:27 pm |
N/A N/A |
Erasca Inc. | ERAS | Casdin Alexander W. Director |
750,000 | $0 | 1,267,724 (Indirect) |
View |
| 2022-06-22 Option Award |
2022-06-24 4:04 pm |
2023-06-22 2032-06-21 |
Erasca Inc. | ERAS | Chen Bihua Director |
40,000 | $0 | 10,712,220 (Direct) |
View |
| 2022-06-22 Option Award |
2022-06-24 09:19 am |
2023-06-22 2032-06-22 |
Erasca Inc. | ERAS | Varney Michael David Director |
60,000 | $0 | 60,000 (Direct) |
View |
| 2022-06-22 Option Award |
2022-06-24 09:18 am |
2023-06-22 2032-06-22 |
Erasca Inc. | ERAS | Multani Pratik S Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2022-06-22 Option Award |
2022-06-24 09:17 am |
2023-06-22 2032-06-22 |
Erasca Inc. | ERAS | Start Valerie Denise Harding Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2022-06-22 Option Award |
2022-06-24 09:17 am |
2023-06-22 2032-06-22 |
Erasca Inc. | ERAS | Hambleton Julie Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2022-06-22 Option Award |
2022-06-24 09:17 am |
2023-06-22 2032-06-22 |
Erasca Inc. | ERAS | Casdin Alexander W. Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2022-06-22 Option Award |
2022-06-24 09:17 am |
2023-06-22 2032-06-22 |
Erasca Inc. | ERAS | Bristol James Arthur Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2022-04-25 Option Award |
2022-04-27 5:55 pm |
N/A 2032-04-24 |
Erasca Inc. | ERAS | LIU JEAN I Director |
80,000 | $0 | 80,000 (Direct) |
View |
| 2022-02-01 Option Award |
2022-02-03 7:56 pm |
N/A 2032-01-31 |
Erasca Inc. | ERAS | Garner Ebun General Counsel & Corp. Sec. |
171,110 | $0 | 173,990 (Direct) |
View |
| 2022-02-01 Other |
2022-02-03 7:56 pm |
N/A N/A |
Erasca Inc. | ERAS | Garner Ebun General Counsel & Corp. Sec. |
990 | $11.6 | 173,990 (Direct) |
View |
| 2022-02-01 Option Award |
2022-02-03 7:54 pm |
N/A 2032-01-31 |
Erasca Inc. | ERAS | Wei Lin Chief Medical Officer |
272,100 | $0 | 587,724 (Direct) |
View |
| 2022-02-01 Other |
2022-02-03 7:54 pm |
N/A N/A |
Erasca Inc. | ERAS | Wei Lin Chief Medical Officer |
1,562 | $11.6 | 587,724 (Direct) |
View |
| 2022-02-01 Option Award |
2022-02-03 7:51 pm |
N/A 2032-01-31 |
Erasca Inc. | ERAS | Lim Jonathan E Chairman & CEO |
791,000 | $0 | 791,000 (Direct) |
View |
| 2022-02-01 Option Award |
2022-02-03 7:39 pm |
N/A 2032-01-31 |
Erasca Inc. | ERAS | Chacko David M. Chief Financial Officer |
366,125 | $0 | 605,185 (Direct) |
View |
| 2022-02-01 Other |
2022-02-03 7:39 pm |
N/A N/A |
Erasca Inc. | ERAS | Chacko David M. Chief Financial Officer |
1,562 | $11.6 | 605,185 (Direct) |
View |
| 2021-07-20 Conversion |
2021-07-22 4:10 pm |
N/A N/A |
Erasca Inc. | ERAS | Chen Bihua Cormorant Global Healthcare Master Fund LP Cormorant Asset Management LP Cormorant Private Healthcare Fund II LP Director |
19,111,106 | $0 | 10,672,219 (Indirect) |
View |
| 2021-07-20 Conversion |
2021-07-20 8:58 pm |
N/A N/A |
Erasca Inc. | ERAS | Lim Jonathan E Lim Conyee T. City Hill LLC See Remarks 10% Owner |
23,268,118 | $0 | 11,899,360 (Indirect) |
View |